Literature DB >> 34927878

A Near-Infrared Organic Fluorescent Probe for Broad Applications for Blood Vessels Imaging by High-Throughput Screening via 3D-Blood Vessel Models.

Muhammad Asri Abdul Sisak1, Fiona Louis2, Ichio Aoki3, Sun Hyeok Lee4,5, Young-Tae Chang4,6, Michiya Matsusaki1.   

Abstract

Blood vessels are present in all of the organs, reflecting their importance for oxygen and nutrient delivery to the cells. Until now, no organic fluorophore has been reported for the live imaging of endothelium although the layer is the key to blood vessel functions. Here, the discovery of a blood vessel organic probe at near-infrared (NIR) wavelength range (BV-NIR) through an engineered blood capillary-based screening system, which is a more physiological model than a conventional cell culture condition, is reported. This selected Cy5 based probe shows the highest specific adsorption property out of 240 candidates on the endothelium and is equivalent to an anti-CD31 antibody in terms of intensity. The BV-NIR probe indicating strong and stable in vitro, ex vivo, and in vivo imaging of the endothelium even after histological immunostaining processes shows potential as a convenient tool for live imaging as well as for covisualization with a specific antibody.
© 2021 Wiley-VCH GmbH.

Entities:  

Keywords:  3D-blood capillary models; antibodies; fibrin gels; fluorescent probes; in vivo imaging

Mesh:

Substances:

Year:  2021        PMID: 34927878     DOI: 10.1002/smtd.202100338

Source DB:  PubMed          Journal:  Small Methods        ISSN: 2366-9608


  2 in total

1.  Mechanism assay of interaction between blood vessels-near infrared probe and cell surface marker proteins of endothelial cells.

Authors:  Muhammad Asri Abdul Sisak; Fiona Louis; Tomoyuki Miyao; Sun Hyeok Lee; Young-Tae Chang; Michiya Matsusaki
Journal:  Mater Today Bio       Date:  2022-06-23

2.  Real-time optical imaging of the hypoxic status in hemangioma endothelial cells during propranolol therapy.

Authors:  Yue Wu; Xiaojuan Yang; Mingrui Zhai; Yi Chen; Xiaoya Lu; Jiandong Ju; Huanqing Zhang; Guanduo Wang; Zhe Zhang; Baocun Zhu; Xuan Wang; Zhanwei Chen; Shengyun Huang
Journal:  Front Oncol       Date:  2022-10-04       Impact factor: 5.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.